Coordinating administrative support for blood research
Official title: Core A: Administrative Core
Funded at Versiti Wisconsin, INC. · NIH-11001970 · Data updated 2026-11-12
This study is all about helping scientists work better together to learn more about how certain sugars in the blood relate to blood diseases, which could eventually lead to better treatments for patients like you.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Versiti Wisconsin, INC. NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project start | January 1, 2021 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $51,995 |
| NIH project number | 5P01HL151333-05 |
| Project ID | NIH-11001970 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation would be individuals involved in or affected by myeloproliferative diseases or those interested in glycobiology.
✕Less likely to help
Patients not affected by blood diseases or those outside the research focus may not receive direct benefits from this research.
What this research studies
This research focuses on providing essential administrative and clinical data coordination for a program investigating the biology of glycans in blood and myeloproliferative diseases. It involves organizing meetings, managing databases of human samples, and facilitating communication among scientists across multiple locations. Patients may benefit indirectly through improved research organization and data management, which can enhance the quality of studies related to blood diseases. The project aims to streamline operations and support scientific leadership within the research community.
Why it matters
Potential benefit: If successful, this research could lead to more efficient and effective studies that improve understanding and treatment of blood-related diseases.
How similar studies have gone: While this approach is primarily administrative, similar initiatives in research coordination have shown to enhance the efficiency and outcomes of scientific studies.
Where this research is happening
-
Versiti Wisconsin, INC.
Milwaukee, United States Active
Researchers
- Principal investigator: Hoffmeister, Karin Maria — Versiti Wisconsin, INC.
- Study coordinator: Hoffmeister, Karin Maria
Related research
Other NIH-funded projects on the same topics.
-
Improving blood safety and availability for transfusions in children and adults
This study is looking to make blood transfusions safer and more accessible for both kids and adults by gathering information from blood donors and recipients across the US and Brazil, so that everyone can benefit from better transfusion practices in the future.
-
Understanding how to safely increase fetal hemoglobin for treating blood disorders
This study is looking at how to safely boost fetal hemoglobin levels in people with blood disorders like beta-thalassemia, by exploring new ways to change certain cells in the body, so that patients can have better treatment options.
-
Understanding how certain proteins regulate blood clotting and cardiovascular diseases
This study is looking at how two proteins that help with blood clotting and heart health work, which could lead to better treatments for blood clotting disorders and heart disease.
-
Targeting a specific gene to treat a type of leukemia
This study is testing a new treatment called AI-10-49 for people with acute myeloid leukemia who have a specific genetic change that makes their condition harder to treat, and it aims to help these patients live longer by killing leukemia cells and working better with other medications.
-
Understanding maternal immune responses affecting newborns with low platelet counts
This study is looking at how a mother's immune system can affect her baby's platelets, which might lead to a serious bleeding condition in newborns, and it aims to find out which pregnancies are at higher risk so that better tests and prevention methods can be developed to help keep babies safe.
-
Understanding the immune response in patients with heparin-induced thrombocytopenia
This study is looking at how the immune system responds to heparin, a blood thinner, to find out more about a serious condition called heparin-induced thrombocytopenia (HIT), and it aims to help doctors better identify harmful antibodies in patients, even if their regular tests come back normal, so they can prevent ser
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.